Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes

OBJECTIVE: To assess the predictive value of the metabolic syndrome in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: Patients were from the prospective Finnish Diabetic Nephropathy (FinnDiane) Study (n = 3,783): mean age 37 ± 12 years and diabetes duration 23 ± 12 years. Metabolic synd...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Thorn, Lena M., Forsblom, Carol, Wadén, Johan, Saraheimo, Markku, Tolonen, Nina, Hietala, Kustaa, Groop, Per-Henrik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2009
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2671127/
https://ncbi.nlm.nih.gov/pubmed/19196885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2022
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak